Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China.
Sichuan Clinical Research Center for Birth Defects, Luzhou, 646000, Sichuan Province, China.
BMC Pediatr. 2024 Nov 6;24(1):708. doi: 10.1186/s12887-024-05184-1.
The effectiveness of acetated Ringer's solution in pediatric shock has received little attention. This study aimed to assess the clinical outcomes of using compound sodium acetate Ringer's solution (AR) for fluid resuscitation in children with septic shock.
We retrospectively analyzed the clinical data of children with septic shock admitted to the pediatric intensive care unit of the Affiliated Hospital of Southwest Medical University from December 2019 to January 2023. Based on the resuscitation fluid administered, the participants were categorized into the compound AR and normal saline (NS) groups. We compared blood circulation conditions, internal environment parameters (arterial blood pH, lactic acid, serum sodium, chloride, calcium, magnesium, potassium, and blood glucose), and 28-day clinical outcomes between the two groups.
This study included 40 children, with 13 and 27 in the compound AR and NS groups, respectively. The two groups showed no significant differences in sex, age, body weight, body mass index, primary inflammation level, or Pediatric Sequential Organ Failure Assessment on admission. Similarly, no significant difference was observed in resuscitation fluid volume administered during the first hour (compound AR group: 250.00 mL [100.00, 390.00]; NS group: 250.00 mL [100.00, 500.00]). The total amount of crystalloid and colloid fluids administered within 24 h, vasoactive drug use, and blood pressure recovery post-resuscitation did not significantly differ between the groups. However, at 6 h post-resuscitation, the compound AR had considerably lower lactate level than the NS group (1.12 vs. 2.20 mmol/L). There were no significant differences in arterial blood pH, serum sodium, chloride, calcium, magnesium, potassium, and blood glucose levels between the groups. After treatment, in the compound AR group, 3 patients died, 2 improved, and 8 were cured. In the NS group, 7 patients died, 8 improved, and 12 were cured. The 28-day treatment outcomes (mortality rate, improvement rate, cure rate, or side effects) showed no significant differences between the groups.
Compound AR was as effective as NS as a resuscitation fluid in pediatric septic shock, demonstrating similar intravascular volume restoration and hemodynamic stability maintenance. However, it caused a faster decline in arterial lactate levels without obvious side effects.
醋酸林格氏液在儿科休克中的疗效尚未得到充分关注。本研究旨在评估复方醋酸钠林格氏液(AR)用于儿童感染性休克液体复苏的临床结局。
我们回顾性分析了 2019 年 12 月至 2023 年 1 月期间在西南医科大学附属医院儿科重症监护病房收治的感染性休克患儿的临床资料。根据所使用的复苏液,将参与者分为复方 AR 组和生理盐水(NS)组。我们比较了两组患儿的血液循环状况、内环境参数(动脉血 pH 值、乳酸、血清钠、氯、钙、镁、钾和血糖)以及 28 天的临床结局。
本研究共纳入 40 例患儿,其中复方 AR 组 13 例,NS 组 27 例。两组患儿的性别、年龄、体重、体重指数、原发炎症水平或入院时的小儿序贯器官衰竭评估无显著差异。同样,复苏后第 1 小时内输入的复苏液量(复方 AR 组:250.00 mL [100.00,390.00];NS 组:250.00 mL [100.00,500.00])也无显著差异。24 小时内输入的晶胶液总量、血管活性药物使用及复苏后血压恢复情况在两组间亦无显著差异。然而,在复苏后 6 小时,复方 AR 组的乳酸水平明显低于 NS 组(1.12 比 2.20 mmol/L)。两组患儿的动脉血 pH 值、血清钠、氯、钙、镁、钾和血糖水平均无显著差异。治疗后,复方 AR 组 3 例死亡,2 例好转,8 例治愈;NS 组 7 例死亡,8 例好转,12 例治愈。两组患儿 28 天治疗结局(病死率、好转率、治愈率或不良反应发生率)无显著差异。
在儿童感染性休克中,复方 AR 作为复苏液与 NS 同样有效,均能恢复有效的血管内容量和维持血流动力学稳定。然而,它能更快地降低动脉血乳酸水平,且无明显不良反应。